Cancer Screening Tests
Tumor-marker collections (e.g., PSA, AFP, CEA, CA-125/CA-15-3/CA-19-9, HE4) support screening in higher-risk individuals and monitor known cancers with imaging/clinical exam.
Physicians order them to flag trends, assess treatment response, or prompt earlier follow-up. Not diagnostic alone, but valuable in longitudinal care.










